QuickView for D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain conserved site 1 (biogroup)

1. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
2. Genomics Assisted Toxicity Evaluation system study - Rat Liver Single Dose
3. Genomics Assisted Toxicity Evaluation system study - Rat Liver Repeat Doses
4. Bone marrow or peripheral blood mononuclear cells of T-cell acute lymphoblastic leukemia patients
5. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations

There were no matches for D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain conserved site 1

There were no clinical trials for D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain conserved site 1